-
Review
January 5, 2024
- Comprehensive approach to controlling chronic hepatitis B in China
- Shan Shan, Xinyan Zhao, Jidong Jia
- Clin Mol Hepatol. 2024;30(2):135-143.
Articles in E-pub version are posted online ahead of regular printed publication.
- Correspondence
- Reply to: “Starting the journey: Understanding the roles of complement proteins in liver diseases through mendelian randomization”
- Yingzhou Shi, Guandou Yuan, Xiude Fan, Chao Xu
- Received April 16, 2024 Accepted April 19, 2024
-
DOI: https://doi.org/10.3350/cmh.2024.0266 [Accepted]
-
View: 21 Download: 3
- Original Article
- Metformin and statins reduce hepatocellular carcinoma risk in chronic hepatitis C patients with failed antiviral therapy
- Pei-Chien Tsai, Chung-Feng Huang, Ming-Lun Yeh, Meng-Hsuan Hsieh, Hsing-Tao Kuo, Chao-Hung Hung, Kuo-Chih Tseng, Hsueh-Chou Lai, Cheng-Yuan Peng, Jing-Houng Wang, Jyh-Jou Chen, Pei-Lun Lee, Rong-Nan Chien, Chi-Chieh Yang, Gin-Ho Lo, Jia-Horng Kao, Chun-Jen Liu, Chen-Hua Liu, Sheng-Lei Yan, Chun-Yen Lin, Wei-Wen Su, Cheng-Hsin Chu, Chih-Jen Chen, Shui-Yi Tung, Chi‐Ming Tai, Chih-Wen Lin, Ching-Chu Lo, Pin-Nan Cheng, Yen-Cheng Chiu, Chia-Chi Wang, Jin-Shiung Cheng, Wei-Lun Tsai, Han-Chieh Lin, Yi-Hsiang Huang, Chi-Yi Chen, Jee-Fu Huang, Chia-Yen Dai, Wan-Long Wan-Long, Ming-Jong Bair, Ming-Lung Yu
- Received January 16, 2024 Accepted April 18, 2025
-
DOI: https://doi.org/10.3350/cmh.2024.0038 [Accepted]
-
View: 60 Download: 3
- Global prevalence of MAFLD-related hepatocellular carcinoma: A systematic review and meta-analysis
- Harry Crane, Guy D. Eslick, Cameron Gofton, Anjiya Shaikh, George Cholankeril, Mark Cheah, Jian-Hong Zhong, Gianluca Svegliati-Baroni, Alessandro Vitale, Beom Kyung Kim, Sang Hoon Ahn, Mi Na Kim, Simone Strasser, Jacob George
- Received February 15, 2024 Accepted April 15, 2024
-
DOI: https://doi.org/10.3350/cmh.2024.0109 [Accepted]
-
View: 168 Download: 19
- Ursolic acid targets secreted phosphoprotein 1 to regulate Th17 cells against non-alcoholic fatty liver disease
- Yiyuan Zheng, Lina Zhao, Zhekun Xiong, Chaoyuan Huang, Qiuhong Yong, Dan Fang, Yugang Fu, Simin Gu, Chong Chen, Jiacheng Li, Yingying Zhu, Jing Liu, Fengbin Liu, Yong Li
- Received January 18, 2024 Accepted April 15, 2024
-
DOI: https://doi.org/10.3350/cmh.2024.0047 [Accepted]
-
View: 170 Download: 23
- Reply to correspondence
- Reply to Correspondence
- Atsumasa Komori
- Received April 9, 2024 Accepted April 10, 2024
-
DOI: https://doi.org/10.3350/cmh.2024.0242 [Accepted]
-
View: 95 Download: 4
- Reply to “Cardiovascular risk of tenofovir disoproxil fumarate or tenofovir alafenamide fumarate in HBV patients”
- Pin-Nan Cheng, Ming-Lung Yu
- Received April 5, 2024 Accepted April 9, 2024
-
DOI: https://doi.org/10.3350/cmh.2024.0228 [Accepted]
-
View: 128 Download: 7
- Original Article
- Ischemia-free liver transplantation improves the prognosis of recipients using Functioned Marginal Liver grafts
- Shuai Wang, Xiaohong Lin, Yunhua Tang, Yichen Liang, Min Zhang, Zhonghao Xie, Yiwen Guo, Yuqi Dong, Qiang Zhao, Zhiyong Guo, Dongping Wang, Xiaoshun He, Weiqiang Ju, Maogen Chen
- Received February 22, 2024 Accepted April 11, 2024
-
DOI: https://doi.org/10.3350/cmh.2024.0139 [Accepted]
-
View: 166 Download: 9
- Conventional and machine-learning based risk score for patients with early-stage hepatocellular carcinoma
- Chun-Ting Ho, Elise Chia-Hui Tan, Pei-Chang Lee, Chi-Jen Chu, Yi-Hsiang Huang, Teh-Ia Huo, Yu-Hui Su, Ming-Chih Hou, Jaw-Ching Wu, Chien-Wei Su
- Received February 9, 2024 Accepted April 10, 2024
-
DOI: https://doi.org/10.3350/cmh.2024.0103 [Accepted]
-
View: 206 Download: 22
- Dynamic Assessment of Modified Quick Sequential Organ Failure Assessment in Acutely Deteriorated Patients with Chronic Liver Disease
- Do Seon Song, Hee Yeon Kim, Young Kul Jung, Tae Hyung Kim, Hyung Joon Yim, Eileen L Yoon, Ki Tae Suk, Jeong-ju Yoo, Sang Gyune Kim, Moon Young Kim, Young Chang, Soung Won Jeong, Jae Young Jang, Sung-Eun Kim, Jung-Hee Kim, Jung Gil Park, Won Kim, Jin Mo Yang, Dong Joon Kim, Ashok Kumar Choudhury, Vinod Arora, Shiv Kumar Sarin
- Received December 27, 2023 Accepted April 9, 2024
-
DOI: https://doi.org/10.3350/cmh.2023.0563 [Accepted]
-
View: 130 Download: 10
- Phase 1 Trial of the Safety, Pharmacokinetics, and Antiviral Activity of EDP-514 in Untreated Viremic Chronic Hepatitis B Patients
- Man-Fung Yuen, Wan-Long Chuang, Cheng-Yuan Peng, Wen-Juei Jeng, Wei-Wen Su, Ting-Tsung Chang, Chi-Yi Chen, Yao-Chun Hsu, Guy De La Rosa, Alaa Ahmad, Ed Luo, Annie L. Conery
- Received December 16, 2023 Accepted March 25, 2024
-
DOI: https://doi.org/10.3350/cmh.2023.0535 [Accepted]
-
View: 308 Download: 27
- Multiomics profiling of buffy coat and plasma unveils etiology-specific signatures in hepatocellular carcinoma
- Jiwon Hong, Jung Woo Eun, Geum Ok Baek, Jae Youn Cheong, Seryoung Park, Soon Sun Kim, Hyo Jung Cho, Su Bin Lim
- Received January 17, 2024 Accepted March 14, 2024
-
DOI: https://doi.org/10.3350/cmh.2024.0042 [Accepted]
-
View: 698 Download: 84
- Sorafenib vs. Lenvatinib in advanced hepatocellular carcinoma after Atezolizumab/Bevacizumab Failure: A real-world study
- Young Eun Chon, Dong Yun Kim, Mina Kim, Beom Kyung Kim, Seung Up Kim, Jun Yong Park, Sang Hoon Ahn, Yeonjung Ha, Joo Ho Lee, Kwan Sik Lee, Beodeul Kang, Jung Sun Kim, Hong Jae Chon, Do Young Kim
- Received December 21, 2023 Accepted March 8, 2024
-
DOI: https://doi.org/10.3350/cmh.2023.0553 [Accepted]
-
View: 587 Download: 110
- Letter to the Editor
- Changing from NAFLD to MASLD: Prevalence and progression of ASCVD risk are similar between NAFLD and MASLD in Asia
- Hiroyuki Suzuki, Tsubasa Tsutsumi, Machiko Kawaguchi, Keisuke Amano, Takumi Kawaguchi
- Received March 1, 2024 Accepted March 5, 2024
-
DOI: https://doi.org/10.3350/cmh.2024.0157 [Accepted]
-
View: 500 Download: 58
- Snapshot
- EXAMINING THE THERAPEUTIC LANDSCAPE OF BETA-BLOCKERS IN PORTAL HYPERTENSION
- Anna Brujats, Càndid Villanueva
- Received February 24, 2024 Accepted March 4, 2024
-
DOI: https://doi.org/10.3350/cmh.2024.0144 [Accepted]
-
View: 414 Download: 17
- Review
- Liver Sinusoidal Endothelial Cell: An Important Yet Often Overlooked Player in the Liver Fibrosis
- Jiaorong Qu, Le Wang, Yufei Li, Xiaojiaoyang Li
- Received January 11, 2024 Accepted February 26, 2024
-
DOI: https://doi.org/10.3350/cmh.2024.0022 [Accepted]
-
View: 620 Download: 86
- Snapshot
- Evaluating the therapeutic efficacy of NAD supplementation in management of metabolic dysfunction-associated steatotic liver disease: Key considerations
- Xinyi Lu, Rui Yang, Yu Chen, Daozhen Chen
- Received December 21, 2023 Accepted December 28, 2023
-
DOI: https://doi.org/10.3350/cmh.2023.0555 [Epub ahead of print]
-
View: 1483 Download: 49
